Related references
Note: Only part of the references are listed.Mitochondrial metabolism, redox signaling, and fusion:: a mitochondria-ROS-HIF-1α-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer
Stephen L. Archer et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Transforming growth factor-beta inhibits telomerase through SMAD3 and E2F transcription factors
Annie Lacerte et al.
CELLULAR SIGNALLING (2008)
The PPARα/p16INK4a Pathway Inhibits Vascular Smooth Muscle Cell Proliferation by Repressing Cell Cycle-Dependent Telomerase Activation
Florence Gizard et al.
CIRCULATION RESEARCH (2008)
Role of telomeres in vascular senescence
Tohru Minamino et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Molecular effects of loss of BMPR2 signaling in smooth muscle in a transgenic mouse model of PAH
Yuji Tada et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-γ activation
Georg Hansmann et al.
CIRCULATION (2007)
A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth
Sebastien Bonnet et al.
CANCER CELL (2007)
Telomere biology and cardiovascular disease
Jose J. Fuster et al.
CIRCULATION RESEARCH (2006)
Trichostatin A, an inhibitor of histone deacetylase, inhibits smooth muscle cell proliferation via induction of p21WAF1
Hiroshi Okamoto et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2006)
Targeting the cell cycle: A new approach to cancer therapy
GK Schwartz et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
PPARα inhibits vascular smooth muscle cell proliferation underlying intimal hyperplasia by inducing the tumor suppressor p16INK4a
F Gizard et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Pre-B-cell colony-enhancing factor regulates NAD+-dependent protein deacetylase activity and promotes vascular smooth muscle cell maturation
E van der Veer et al.
CIRCULATION RESEARCH (2005)
Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension
MS McMurtry et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Survivin expression is up-regulated in vascular injury and identifies a distinct cellular phenotype
HF Simosa et al.
JOURNAL OF VASCULAR SURGERY (2005)
The mTOR/p70 S6K1 pathway regulates vascular smooth muscle cell differentiation
KA Martin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2004)
Opposing regulatory roles of E2F in human telomerase reverse transcriptase (hTERT) gene expression in human tumor and normal somatic cells
JJ Won et al.
FASEB JOURNAL (2002)
A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.
M Morice et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
FKBP12-rapamycin-associated protein associates with mitochondria and senses osmotic stress via mitochondrial dysfunction
BN Desai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Hypoxia extends the life span of vascular smooth muscle cells through telomerase activation
T Minamino et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation
VM Richon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Peroxisome proliferator-activated receptor γ ligands inhibit retinoblastoma phosphorylation and G1 → S transition in vascular smooth muscle cells
S Wakino et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16INK4a and Cdk2/Cyclin E complex activation
A Suzuki et al.
ONCOGENE (2000)
Share Paper
